Cleveland Clinic to use IBM Watson for Genomic Research - Decide Software

Cleveland Clinic to use IBM Watson for Genomic Research: Researchers at Cleveland Clinic will use IBM Watson technology in the area of genomic research to help oncologists deliver personalized medicine by uncovering new cancer treatment options for patients. The Lerner Research Institute's Genomic Medicine Institute at Cleveland Clinic plans to evaluate Watson's ability to help oncologists develop more personalized care to patients for a variety of cancers. Clinicians lack the tools and time required to bring DNA-based treatment options to their patients and to do so, they must correlate data from genome sequencing to reams of medical journals, new studies and clinical records. At a time when medical information is doubling every five years, a faster option is needed. This use of Watson aims to find the "needle in the haystack" through identifying patterns in genome sequencing and medical data to unlock insights that will help clinicians bring the promise of genomic medicine to their patients.